Almac Group Executive to Speak at IQPC Clinical Trial Supply Europe 2017

January 12, 2017

Supply Chain Solutions Manager Shares Expertise on the Regulatory Impacts of Temperature Management

Craigavon, N.I., 12 January 2017Almac Group, the global contract pharmaceutical development and manufacturing organization, has announced that Heather Bogle, Supply Chain Solutions Manager, Almac Clinical Services, will speak at this years’ Clinical Trial Supply Europe conference, being held in London from 23 January until 25 January.

Ms Bogle’s presentation, entitled “Regulatory Impact: Technology, Tools, and Insight to Mitigate Risk”, will take place on day two (24th January) of the conference where she will share the platform with a growing list of industry experts from across the globe.

During her talk, Heather will share her expertise and in-depth knowledge on a range of key considerations regarding understanding the challenges of staying compliant in the realm of Temperature Management and will discuss case studies on how processes, technology and tools are implemented. In addition, Heather will also be examining global case studies on how to reduce errors, improve efficiencies and develop compliance.

Heather Bogle graduated from Queens University, Belfast with a BSc in Chemistry. She joined Almac in 2001 and has worked with a wide range of Pharma and Biotech companies, from small specialist providers to multinationals, to manage supply chains across the full range of sponsors and trial designs. Heather has first-hand experience in managing the supply chain for studies across the globe with temperature sensitive products. She has expert knowledge on the challenges with temperature management through the supply chain and extensive experience in developing creative, efficient and robust solutions.

About Almac Group

‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organization that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialization, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).



Back to news